Traws Pharma enters ATM equity facility for up to $50M with Citizens JMP Securities

Traws Pharma, Inc.

ATM agreement allows sale of common stock up to $50M aggregate, subject to baby shelf limit of $5,514,200.
Shares sold at market prices on Nasdaq via Citizens JMP as agent; commission is 3% of gross proceeds.
Prospectus supplement dated March 10, 2025 filed under Rule 424(b); Company not obligated to sell any shares.
ATM may be terminated by Company with 5 business days' notice or by Manager at any time.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.